ALDOMET TAB 125MG 125 MG
METHYLDOPA : 125 MG · DIN 00016551 · MERCK FROSST CANADA & CIE, MERCK FROSST CANADA & CO.
Health Canada status: CANCELLED POST MARKET
What is ALDOMET TAB 125MG?
ALDOMET TAB 125MG 125 MG contains METHYLDOPA : 125 MG. It is listed in the Health Canada Drug Product Database under DIN 00016551, held by MERCK FROSST CANADA & CIE, MERCK FROSST CANADA & CO., supplied as TABLET for ORAL administration. Health Canada currently lists it as cancelled post market, status dated 14-Aug-1998. Nexara Health is a licensed Canadian wholesale distributor (DEL 3-002896-A) and can source this product for hospitals, pharmacies and clinics. Availability and lead time are confirmed per order.
What else is ALDOMET TAB 125MG called?
The same molecule, METHYLDOPA (RACEMIC), is registered under other names elsewhere. Buyers and prescribers searching from outside Canada — or working from a foreign prescription or tender document — often know it by one of these:
| Name | Script | Registered in |
|---|---|---|
| Aldomet | Latin | Australia, Bahrain, Morocco, Saudi Arabia |
| Presinol | Latin | Iceland |
| ALDOPA | Latin | Morocco |
| Hydopa | Latin | Australia |
Names are taken from national medicine registers and published price lists. A product registered abroad is not authorized for sale in Canada unless it holds its own DIN; import is possible only through the routes Health Canada permits.
Product details and regulatory record
| DIN | 00016551 |
|---|---|
| Brand name | ALDOMET TAB 125MG |
| Generic / active ingredient | METHYLDOPA : 125 MG |
| Manufacturer | MERCK FROSST CANADA & CIE, MERCK FROSST CANADA & CO. |
| Strength | 125 MG |
| Dosage form | TABLET |
| Route of administration | ORAL |
| Schedule | Prescription |
| ATC code | C02AB02 METHYLDOPA (RACEMIC) |
| Biosimilar | No |
| Health Canada status | CANCELLED POST MARKET |
| Status date | 14-Aug-1998 |
How is this product identified?
Purchase orders, customs paperwork and tender documents each ask for a different identifier, and a DIN written without its leading zeros is the single most common reason an order line fails to match. Every form Nexara accepts for this product is listed here.
| DIN (8-digit, as used in Nexara ordering) | 00016551 |
|---|---|
| DIN (unpadded, as printed on some documents) | 16551 |
| Brand name | ALDOMET TAB 125MG |
| Active ingredient / INN | METHYLDOPA : 125 MG |
| ATC code | C02AB02 |
| ATC anatomical main group | C — Cardiovascular system |
| ATC therapeutic subgroup | C02 |
| Health Canada schedule | Prescription |
| Biosimilar biologic | No |
| Market authorization holder | MERCK FROSST CANADA & CIE, MERCK FROSST CANADA & CO. |
Which pack is which?
| Strength on the label | 125 MG |
|---|---|
| Dosage form | TABLET |
| Route | ORAL |
One DIN can cover more than one pack size, and the pack — not the DIN — is what gets priced, shipped and invoiced. Before an order line is unambiguous Nexara needs the strength, the pack size and the presentation.
What can be used instead?
Other Canadian products sharing ATC code C02AB02 METHYLDOPA (RACEMIC). 3 of 20 DINs in this group are currently marketed — marketed products are listed first, because that is what can actually be bought. These tables describe supply, not clinical equivalence: substitution rests with the prescriber or pharmacist, and interchangeability is determined provincially.
| Product | Strength | Form | Manufacturer | Health Canada status | DIN |
|---|---|---|---|---|---|
| METHYLDOPA | 125 MG | TABLET | AA PHARMA INC | MARKETED | DIN 00360252 |
| METHYLDOPA | 250 MG | TABLET | AA PHARMA INC | MARKETED | DIN 00360260 |
| METHYLDOPA | 500 MG | TABLET | AA PHARMA INC | MARKETED | DIN 00426830 |
| ALDOMET ESTER HCL INJ | 250 MG / 5 ML | LIQUID | MERCK FROSST CANADA & CIE, MERCK FROSST CANADA & CO. | CANCELLED POST MARKET | DIN 00016187 |
| ALDOMET TAB 250MG | 250 MG | TABLET | MERCK FROSST CANADA & CIE, MERCK FROSST CANADA & CO. | CANCELLED POST MARKET | DIN 00016578 |
| ALDOMET TAB 500MG | 500 MG | TABLET | MERCK FROSST CANADA & CIE, MERCK FROSST CANADA & CO. | CANCELLED POST MARKET | DIN 00016586 |
| DOPAMET TAB 125MG | 125 MG | TABLET | ICN CANADA LTD. | CANCELLED POST MARKET | DIN 00353620 |
| DOPAMET TAB 250MG | 250 MG | TABLET | ICN CANADA LTD. | CANCELLED POST MARKET | DIN 00250392 |
| DOPAMET TAB 500MG | 500 MG | TABLET | ICN CANADA LTD. | CANCELLED POST MARKET | DIN 00353639 |
| MEDIMET 250TAB | 250 MG | TABLET | MEDIC LABORATORY LTÉE | CANCELLED POST MARKET | DIN 00385077 |
Who else supplies METHYLDOPA (RACEMIC) worldwide?
Nexara tracks national medicine registries and published price lists across multiple markets. METHYLDOPA (RACEMIC) appears in 7 registered pack listings across 2 markets, published on 2 different national price bases. Where a Canadian route is closed, that is where an alternative route of supply starts — subject to the import rules in both countries.
Registered listings are not stock. Ask us to confirm what can actually be sourced for your order.
How much does METHYLDOPA (RACEMIC) cost around the world?
METHYLDOPA (RACEMIC) is listed on 8 national price registers Nexara tracks, across 19 pack listings published on 7 different price bases. What each country publishes is set out below.
| Market | What that country publishes | Brands listed | Pack listings | As of |
|---|---|---|---|---|
| Saudi Arabia | public | 5 | 7 | 01 Sep 2026 |
| Morocco | PPV (public price) | 2 | 3 | 05 Sep 2026 |
| Australia | ex-manufacturer | 2 | 2 | 08 Sep 2026 |
| United Kingdom | hospital | 2 | 2 | 31 Aug 2026 |
| Iceland | max wholesale | 1 | 2 | 02 Sep 2026 |
| United Arab Emirates | public | 1 | 1 | 31 Aug 2026 |
| Bahrain | retail (max) | 1 | 1 | 01 Sep 2026 |
| South Africa | single exit price | 1 | 1 | 01 Sep 2026 |
Why there are no figures here. These bases are not comparable. A Brazilian ex-factory ceiling, a Belgian pharmacy public price and a Japanese reimbursement rate answer three different questions, and none of them is what a product lands in Canada for. Putting them side by side would mislead in both directions, so Nexara publishes where a molecule is listed and on what basis, and quotes the delivered Canadian price per order.
Can this still be bought in Canada?
No. This Drug Identification Number is cancelled post market in Health Canada's Drug Product Database, so the product is no longer authorized for sale in Canada and Nexara does not supply it. This page is kept as a regulatory record.
If you are looking for a current equivalent, the alternatives above list every product sharing this therapeutic class, with the marketed ones first. Ask us to source an alternative
Ordering questions
Who can buy this from Nexara?
Licensed entities only. Nexara holds Health Canada establishment licence DEL 3-002896-A and ships only to a licensed address.
Is there a minimum order?
Yes, set per product line and per pack multiple rather than on the order total, so you are never asked to buy a part-pack. The minimum for this line is confirmed with your quote.
What is the lead time?
Confirmed per order at quotation, and it depends on current stock position and whether the product is in shortage.
Can Nexara supply this for a clinical trial?
Yes — comparator and background-therapy supply, including sourcing from other markets where a Canadian pack will not satisfy the protocol. Clinical trial supply.